Private Equity Firms in New York
43 mid-market firms headquartered in New York. Sector focus, check size, and investment criteria for each, drawn from the firms' own published materials.
New York is the deepest pool of mid-market sponsors in the country, and the most specialised. Most of the firms below run narrow theses, healthcare provider services, branded consumer, vertical software, rather than generalist buyout, and the majority write cheques into businesses with $5M to $40M of EBITDA. Expect a crowded, fast process and a diligence team that has seen your category many times before.
37 of 43 are based in New York. Most common sector focus: Healthcare, Consumer, Software & Technology. Published EBITDA targets: 1 at Under $5M, 9 at $5M-$15M, 9 at $15M-$40M, 4 at $40M+.
- Assured Healthcare Partners
Exclusively healthcare, with a preference for provider services businesses that do not carry direct reimbursement risk.
- BelHealth Investment Partners
A New York healthcare investor spanning services, products, and distribution at the smaller end of the market.
- Brand Velocity Group
A New York consumer specialist that buys brands with $10M+ EBITDA and applies a marketing-led playbook.
- Branford Castle Partners
A New York firm hunting below the radar: specialty manufacturing, industrials, and transportation companies up to $15M EBITDA with a $3M to $10M sweet spot.
- Bregal Partners
The North American lower-middle-market arm of the Bregal family, backing founder-owned consumer, multi-unit, food, and business services companies up to $75M of EBITDA.
- Bregal Sagemount
Sagemount invests $20M to $400M in growth companies across software, tech-enabled services, healthcare IT, and fintech, needing only $7M of revenue to engage.
- Bruckmann, Rosser, Sherrill & Co. (BRS)
BRS has been doing consumer and multi-unit deals in New York since 1995, from restaurant groups to specialty distribution, across a wide $1M to $25M EBITDA range.
- Centre Partners
One of New York's veteran mid-market shops, focused on founder- and family-owned consumer and healthcare companies with $5M to $40M of EBITDA.
- CIP Capital
A New York firm investing $25M to $125M in tech-enabled business services, business information, and knowledge services companies with $5M to $25M+ of EBITDA.
- Coalesce Capital
A newer New York firm with a $900M debut fund focused on human-capital-driven and tech-enabled services: compliance, facility services, HR outsourcing.
- Concord Health Partners
A healthcare investor with an unusual LP base that includes the American Hospital Association, giving portfolio companies direct access to hospital-system buyers.
- Consonance Capital Partners
New York healthcare-only investors focused exclusively on the U.S.
- Consumer Growth Partners
A White Plains specialist in specialty retail and branded consumer products with at least $2M of EBITDA.
- Dunes Point Capital
A Rye, New York family office turned institutional investor, buying industrial technology and building products platforms with $10M to $75M of EBITDA and bolting on companies from $2M up.
- Enhanced Healthcare Partners
A New York healthcare-only firm whose $521M second fund closed oversubscribed in 2025.
- Garnett Station Partners
A New York firm built on multi-site consumer: restaurants, car washes, health services, franchise platforms.
- GenNx360 Capital Partners
A New York firm buying industrial services, manufacturing, transportation, and logistics companies with $5M to $35M of EBITDA.
- Grant Avenue Capital
A New York healthcare firm led by a former Apax healthcare partner, with $623M AUM across services and medical products.
- Graycliff Partners
A New York firm descended from HSBC's private capital arm, investing $10M to $100M in niche manufacturing, distribution, and industrial services companies with $4M to $50M of EBITDA.
- Health Enterprise Partners
A New York healthcare IT investor whose LP base includes dozens of hospital systems and health plans, which double as customer introductions for portfolio companies.
- High Road Capital Partners
A New York firm buying niche manufacturing, distribution, and services companies with $1M to $10M of EBITDA.
- ICV Partners
A New York firm investing in business services, non-discretionary consumer services, and food companies with $5M to $15M of EBITDA.
- InTandem Capital Partners
A New York healthcare services firm with a $715M third fund, focused on provider services businesses without direct reimbursement exposure.
- Lead Edge Capital
A New York growth firm with a $3.5B seventh fund investing $50M to $400M in software and internet businesses with $10M+ revenue.
- Long Ridge Equity Partners
A New York firm investing $25M to $150M in financial and business technology companies with $5M+ revenue.
- MidOcean Partners
A New York firm with $11B+ AUM investing $50M to $300M+ in consumer and business services companies with enterprise values from $150M to $750M+.
- New MainStream Capital
A New York firm (often shortened to NMS Capital) investing $25M to $75M in healthcare and business services companies with $5M to $25M of EBITDA.
- NexPhase Capital
A New York firm with $2.6B raised, running thesis-driven plays across healthcare, software, and consumer.
- Palladium Equity Partners
A New York firm with ~$3.6B AUM investing $50M to $150M in consumer, services, industrial, and healthcare companies with $10M to $75M of EBITDA.
- Prelude Growth Partners
A New York consumer growth firm with a $600M third fund, investing $15M to $75M in high-growth beauty, wellness, and food brands.
- Radian Capital
A New York firm investing $10M to $60M in B2B software and services companies with $5M+ ARR.
- Regal Healthcare Capital Partners
A New York healthcare services firm whose $610M fourth fund closed above target in 2026.
- Saw Mill Capital
A Briarcliff Manor firm investing $15M to $100M per platform in engineered products, specialty distribution, and industrial services companies with $3M to $25M of EBITDA.
- Spire Capital
A New York firm investing $15M to $125M in tech-enabled business services, media, education, and communications companies from $2M of EBITDA.
- Stellex Capital Management
A New York and London firm investing $75M to $150M in industrial, consumer, and food businesses, with real appetite for operational complexity, carve-outs, and turnarounds.
- Tenex Capital Management
A New York firm with a $1.9B fourth fund investing $25M to $125M in industrials, services, and healthcare companies with $3M to $40M of EBITDA.
- The Riverside Company
One of the largest small-company investors in the world, with strategies spanning micro-cap (under $10M EBITDA), capital appreciation ($10M to $35M), flexible capital, and software acceleration.
- Topspin Consumer Partners
A Mamaroneck firm investing $10M to $50M in consumer companies across wellness, personal care, food, pet, and children's products with EBITDA up to $25M.
- TZP Group
A New York firm managing ~$2B across strategies, investing $10M to $100M in consumer and business services companies with $2M to $15M of EBITDA.
- V&A Capital (Vanda Capital)
A New York firm buying manufacturing, distribution, and transportation businesses with $1M to $10M of EBITDA.
- Vertica Capital Partners
A New York software firm with $1B+ AUM investing $15M to $200M in enterprise and vertical software companies with $2M to $20M of ARR.
- Vesey Street Capital Partners
A New York healthcare services firm with ~$942M AUM investing $75M to $120M in businesses with $10M to $20M of EBITDA.
- Zenyth Partners
A New York healthcare firm with a $375M second fund building consumer-facing healthcare services platforms: dental, vision, MSK, and similar multi-site categories.
New York buyers will test your numbers before they trust them.
Crawford McMillan gets mid-market companies diligence-ready: revenue you can trace, metrics you can defend, reporting that holds up in a data room. Free weekly brief on what buyers actually look for.
Get Inside the Data Room